Cite Filings / CADL
Feed Companies Filings Check
Sign in

CIK 0001841387 · <br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
Filings Insiders Search text
All 422 Financials 111 Shareholder Meetings 5 Executive Compensation 99 Insider Trading 202 Beneficial Ownership Interest 22 Business Combinations 87 Public Offerings 30 Mutual Funds and ETFs 5 Others 57
›
Filed in
  1. No filings match these filters. Clear filters
  2. 10-K Report Annual Report 2022-03-29
  3. 8-K Event ● Results of operations 2022-03-29
  4. 8-K Event ● Material agreement · New debt or obligation · Regulation FD disclosure 2022-03-01
  5. 8-K Event Other events 2022-02-09
  6. 8-K Event ● Executive or director change 2022-01-31
  7. 10-Q Report Quarterly Report 2021-11-12
  8. 8-K Event ● Results of operations 2021-11-12
  9. 10-Q Report Quarterly Report 2021-09-08
  10. 8-K Event ● Results of operations 2021-09-08
  11. 8-K Event Other events 2021-08-17
  12. 8-K Event ● Executive or director change · Bylaws or fiscal year change 2021-07-30

Page 6 of 6 · 111 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…